See also this year's filing and all EDGAR filings for this company.
PDF Report 0001621221_2019_Artelo_Biosciences_INC.pdf
Logs
| warning | The stock_price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001621221, Artelo Biosciences INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 396,435 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 563 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 531,972 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 2,512,002 |
| 9 | ResearchAndDevelopmentExpense | 1,249,854 |
| 10 | remainder_Expenses | 2,885,873 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -1,356 |
| 13 | remainder_ComprehensiveNetIncome | 656 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 396,998 |
| 1 | Liabilities | 531,972 |
| 2 | Expenses | 6,647,729 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -134,974 |
| 5 | NetIncome | -6,649,085 |
| 6 | ComprehensiveNetIncome | -6,648,757 |
| 7 | BaseVar | 3,789,356 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -14.9 |
| 9 | EconomicCapitalRatio | 0.0000000243 |